Nanobiotix (NBTX) Other Non-Current Liabilities (2019 - 2025)

Nanobiotix's Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $590170.1 for Q4 2025.

• On a quarterly basis, Other Non-Current Liabilities rose 27.84% year-over-year to $590170.1 in Q4 2025; TTM through Dec 2025 was $590170.1, a 27.84% increase from a year earlier, with the FY2025 full-year figure at $572814.3, up 24.08% from the prior year.
• Other Non-Current Liabilities advanced to $590170.1 in Q4 2025 per NBTX's latest filing, from $542208.7 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $590170.1 in Q4 2025 and bottomed at $266764.2 in Q2 2022.
• The 5-year median for Other Non-Current Liabilities is $376269.6 (2021), against an average of $412096.3.
• Across the five-year window, Other Non-Current Liabilities tumbled 51.53% in 2022 and jumped 39.47% in 2025, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $363782.8 in 2021, then fell by 24.28% to $275466.8 in 2022, then climbed by 26.16% to $347528.6 in 2023, then jumped by 32.83% to $461633.2 in 2024, then grew by 27.84% to $590170.1 in 2025.
• Per Business Quant, the three latest NBTX Other Non-Current Liabilities figures stand at $590170.1 (Q4 2025), $542208.7 (Q2 2025), and $461633.2 (Q4 2024).